CreatorsPublishersAdvertisers
View more in
Health

Oramed hits 50% enrollment in Phase 2 trial for oral insulin capsule

drugdeliverybusiness.com
 2021-09-15

Cover picture for the articleNew York-based Oramed’s Phase 2 trial evaluates its oral insulin capsule ORMD-0801 for the treatment of non-alcoholic steatohepatitis (NASH), with patients continuing to be screened at sites in the U.S. and Israel, according to a news release. The double-blind, multi-center trial assesses the safety and potential efficacy of the drug...

www.drugdeliverybusiness.com

Comments / 0

Comments / 0